Latest: Pulmonary cardiology: Circulating immune cells and the pathogenesis of pulmonary...
Latest: Meet the researcher working towards a vaccine against parasites blighting the poultry...
Latest: The future of protein biology research in drug discovery
Latest: Top resources for cannabis potency testing
Latest: Download 4 infographics on sample prep techniques for GC and GC-MS
Latest: Standard oven drying methods vs. TGM800: Direct moisture determination
Latest: Shaping the future of polymer R&D: Advances in atomic force microscopy
Regenerative medicine technique development and the importance of cooperative research
Pulmonary cardiology: Circulating immune cells and the pathogenesis of pulmonary arterial...
Rapidly acquire quantitative data from cell-based assays
Andor launches new microscopy camera designed to meet the needs of challenging applications
An automated metabolite extraction method for plasma: Your questions answered
Secondary ion mass spectroscopy workshop: Sensitive compositional analysis at the micro- and...
HPLC: Improved sample preparation for high-sensitivity analysis
Development of Antibody-Based Cancer Therapeutics
Smart technology to keep your freezers free of frost
What is Six Sigma and how does it apply to control materials?
Quickly and easily measure electrical network behaviours in live cells at high throughput
Biophysical Characterization Technology
Cell Imaging Technology
25 Jan 20 - 29 Jan 20
01 Mar 20 - 04 Mar 20
01 Mar 20 - 05 Mar 20
31 Mar 20 - 03 Apr 20
AACR Annual Meeting 2020
24 Apr 20 - 29 Apr 20
The EXPRESS-Pick small molecule screening compound stock is a collection of 460,000 druglike, small molecule compounds, available for custom selection.
Structurally diverse small molecule libraries with broad 3D pharmacophore coverage for hit identification
ChemBridge offers two, complementary DIVERSet™ Libraries, each composed of 50,000 leadlike and druglike compounds. Both DIVER... Read more...
CNS-directed selection from ChemBridge's EXPRESS-Pick Collection screening compound stock.
Pre-plated selection from ChemBridge's EXPRESS-Pick Collection screening compound stock.
Ion channel-directed selection from ChemBridge's EXPRESS-Pick Collection screening compound stock.
GPCR-targeted compounds based on beta-turn mimetic scaffolds designed by ChemBridge.
Kinase-directed selection from ChemBridge's EXPRESS-Pick Collection screening compound stock.
Kinase-directed selection from ChemBridge's CORE Library screening compound stock.
Peakdale has built up medicinal chemistry and computational chemistry expertise across therapeutic areas and spanning the drug discovery process from hit generation to Phase I clinical studies. Peakdale has a proven track record of suc... Read more...